Genetic Engineering & Biotechnology News

SEP1 2013

Genetic Engineering & Biotechnology News (GEN) is the world's most widely read biotech publication. It provides the R&D; community with critical information on the tools, technologies, and trends that drive the biotech industry.

Issue link: http://gen.epubxp.com/i/155541

Contents of this Issue

Navigation

Page 36 of 61

"X-tremeGENE is by far the best transfection reagent I've ever used." Alan Alfano Cancer Researcher University of Maryland School of Medicine, Baltimore, MD See more of Alan�s story at go.roche.com/alan Alan has been compensated for his testimonial. The comments and opinions presented in this interview are reflective of his personal experience with this product. For life science research only. Not for use in diagnostic procedures. X-TREMEGENE is a trademark of Roche. Confdence. Inspired by Results. " In cancer research, achieving uniform results with transfection is often a big hurdle. I've used a number of types of reagents and protocols for transfections, and X-tremeGENE HP DNA Transfection Reagent is both easy and fast. The expression levels in each cell line are higher and a lot more consistent, regardless of the environment." " It's nice to know that with all the potential obstacles I might encounter in my research, transfection isn't one of them." X-tremeGENE DNA Transfection Reagents. Transfect with confdence. Roche Diagnostics Corporation Roche Applied Science Indianapolis, Indiana © 2013 Roche Diagnostics. All rights reserved.

Articles in this issue

Links on this page

Archives of this issue

view archives of Genetic Engineering & Biotechnology News - SEP1 2013